Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > End of Q3

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Jul 05, 2024 4:21pm

135 Views

Post# 36120461

RE:RE:RE:End of Q3

@Plantrader: Thank you. Probably a more realistic timeline. Let's hope they are able to submit the pre-BTD on time and get the money they need for Q4. I am assuming we will get an update in the Q2 report sometime in July or August, unless we get an NR specific to the submission before then.

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"